Cargando…
Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), bronchial responsiveness after acute administration of short acting bronchodilators is conventionally assessed by measuring the improvement of forced expiratory volume in the first second (FEV(1)) during a maximal forced expirat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360132/ https://www.ncbi.nlm.nih.gov/pubmed/35851429 http://dx.doi.org/10.1007/s00408-022-00556-9 |
_version_ | 1784764285855989760 |
---|---|
author | Pini, Laura Ziletti, Giulia Claudia Ciarfaglia, Manuela Giordani, Jordan Tantucci, Claudio |
author_facet | Pini, Laura Ziletti, Giulia Claudia Ciarfaglia, Manuela Giordani, Jordan Tantucci, Claudio |
author_sort | Pini, Laura |
collection | PubMed |
description | PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), bronchial responsiveness after acute administration of short acting bronchodilators is conventionally assessed by measuring the improvement of forced expiratory volume in the first second (FEV(1)) during a maximal forced expiratory maneuver. This study aimed to measure the variation of intrathoracic airway wall compliance (AWC) after acute administration of short acting beta-2 agonist in COPD patients since this might influence the final modification of airway caliber during maximal expiratory effort and the resulting bronchodilation as inferred by FEV(1) changes. METHODS: In a group of 10 patients suffering from COPD, intrathoracic AWC was measured at middle (50% of Forced Vital Capacity (FVC) and low (75% of FVC) lung volumes using the interrupter method during forced expiratory maneuver in basal conditions and after acute inhalation of albuterol (salbutamol) (400 mcg by MDI). Ten healthy subjects were examined similarly as a control group. RESULTS: Lower values of baseline intrathoracic AWC at both lung volumes were found in COPD patients (1.72 ± 0.20 ml/cmH(2)O and 1.08 ± 0.20 ml/cmH(2)O, respectively) as compared to controls (2.28 ± 0.27 ml/cmH(2)O and 1.44 ± 0.22 ml/cmH(2)O, respectively) (p < 0.001). In COPD patients, AWC increased significantly at both lung volumes after salbutamol, amounting to 1.81 ± 0.38 ml/cmH(2)O and 1.31 ± 0.39 ml/cmH(2)O, respectively (p < 0.01), but the relative change was not different from that observed in controls. CONCLUSION: In COPD patients, AWC is reduced compared to controls, but after bronchodilator, the intrathoracic airways become more compliant. The consequent increased collapsibility under high positive pleural pressure could limit the airway caliber improvement seen after bronchodilator, as assessed by the FEV(1) changes during the forced expiratory maneuver, underestimating the effective bronchodilation achieved in these patients. |
format | Online Article Text |
id | pubmed-9360132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93601322022-08-10 Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients Pini, Laura Ziletti, Giulia Claudia Ciarfaglia, Manuela Giordani, Jordan Tantucci, Claudio Lung COPD PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), bronchial responsiveness after acute administration of short acting bronchodilators is conventionally assessed by measuring the improvement of forced expiratory volume in the first second (FEV(1)) during a maximal forced expiratory maneuver. This study aimed to measure the variation of intrathoracic airway wall compliance (AWC) after acute administration of short acting beta-2 agonist in COPD patients since this might influence the final modification of airway caliber during maximal expiratory effort and the resulting bronchodilation as inferred by FEV(1) changes. METHODS: In a group of 10 patients suffering from COPD, intrathoracic AWC was measured at middle (50% of Forced Vital Capacity (FVC) and low (75% of FVC) lung volumes using the interrupter method during forced expiratory maneuver in basal conditions and after acute inhalation of albuterol (salbutamol) (400 mcg by MDI). Ten healthy subjects were examined similarly as a control group. RESULTS: Lower values of baseline intrathoracic AWC at both lung volumes were found in COPD patients (1.72 ± 0.20 ml/cmH(2)O and 1.08 ± 0.20 ml/cmH(2)O, respectively) as compared to controls (2.28 ± 0.27 ml/cmH(2)O and 1.44 ± 0.22 ml/cmH(2)O, respectively) (p < 0.001). In COPD patients, AWC increased significantly at both lung volumes after salbutamol, amounting to 1.81 ± 0.38 ml/cmH(2)O and 1.31 ± 0.39 ml/cmH(2)O, respectively (p < 0.01), but the relative change was not different from that observed in controls. CONCLUSION: In COPD patients, AWC is reduced compared to controls, but after bronchodilator, the intrathoracic airways become more compliant. The consequent increased collapsibility under high positive pleural pressure could limit the airway caliber improvement seen after bronchodilator, as assessed by the FEV(1) changes during the forced expiratory maneuver, underestimating the effective bronchodilation achieved in these patients. Springer US 2022-07-18 2022 /pmc/articles/PMC9360132/ /pubmed/35851429 http://dx.doi.org/10.1007/s00408-022-00556-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | COPD Pini, Laura Ziletti, Giulia Claudia Ciarfaglia, Manuela Giordani, Jordan Tantucci, Claudio Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients |
title | Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients |
title_full | Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients |
title_fullStr | Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients |
title_full_unstemmed | Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients |
title_short | Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients |
title_sort | acute effect of bronchodilator on intrathoracic airway wall compliance in copd patients |
topic | COPD |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360132/ https://www.ncbi.nlm.nih.gov/pubmed/35851429 http://dx.doi.org/10.1007/s00408-022-00556-9 |
work_keys_str_mv | AT pinilaura acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients AT zilettigiuliaclaudia acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients AT ciarfagliamanuela acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients AT giordanijordan acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients AT tantucciclaudio acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients |